Hexamethylbenzene

Hexamethylbenzene

SCHEMBL9419367

Cc1c(C)c(C)c(C)c(C)c1C.Cc1c(C)c(C)c(C)c(C)c1C.[Cr]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5321105-A Polymerization process using a bimodal silica gel as a catalyst support QUANTUM CHEMICAL CORPORATION (US) 1994-06-14 US claimed
US-5231066-A Bimodal silica gel, its preparation and use as a catalyst support QUANTUM CHEMICAL CORPORATION (US) 1993-07-27 US claimed
US-20250361254-A1 HIGH PURITY BIS (ARENE) METAL COMPLEXES ENTEGRIS INC (US) 2025-11-27 US disclosed
WO-2025245301-A1 HIGH PURITY BIS (ARENE) METAL COMPLEXES ENTEGRIS, INC. (US) 2025-11-27 WO disclosed
EP-4476233-A1 ORGANOMETALLIC PRECURSORS AND RELATED METHODS Entegris, Inc. (US) 2024-12-18 EP disclosed
CN-118804919-A Organometallic precursors and related methods 恩特格里斯公司 2024-10-18 CN disclosed
US-20230271987-A1 ORGANOMETALLIC PRECURSORS AND RELATED METHODS ENTEGRIS, INC. 2023-08-31 US disclosed
WO-2023154404-A1 ORGANOMETALLIC PRECURSORS AND RELATED METHODS ENTEGRIS, INC. (US) 2023-08-17 WO disclosed
EP-0293595-B1 Ionomer resin and preparation of same IDEMITSU KOSAN CO (JP) 1994-01-05 EP disclosed
US-5270420-A Ethylene-acrylic copolymer IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-14 US disclosed
EP-0356692-B1 Process for production of stretched moldings IDEMITSU KOSAN CO (JP) 1993-12-01 EP disclosed
EP-0193146-A2 Process for production of ethylene-based polymers IDEMITSU KOSAN COMPANY LIMITED (JP) 1986-09-03 EP disclosed
US-4526724-A Process for the preparation of zero valent bis-arene transition metal compounds STANDARD OIL COMPANY (INDIANA) (US) 1985-07-02 US disclosed
US-4444968-A SENSITIVITY TO HYDROGEN PHILLIPS PETROLEUM COMPANY (US) 1984-04-24 US disclosed
US-4364841-A POLYMERIZATION CATALYST FOR ALPHA-OLEFINS PHILLIPS PETROLEUM COMPANY (US) 1982-12-21 US disclosed
EP-0055865-A2 Catalyst, method of making and use of same for polymerizing olefins PHILLIPS PETROLEUM COMPANY (US) 1982-07-14 EP disclosed
US-4188471-A DIBENZENE CHROMIUM OR DICUMENE CHROMIUM ON SILICA-TITANIA SUPPORT PHILLIPS PETROLEUM COMPANY (US) 1980-02-12 US disclosed
US-RE29504-E Unsaturated hydrocarbons polymerization catalysts containing transition metal complexes and Bronsted acids INSTITUT FRANCAIS DU PETROLE, DES CARBURANTS ET LUBRIFIANTS (FR) 1977-12-27 US disclosed
US-4001196-A Reactivation of organochromium olefin polymerization catalyst in presence of oxygen PHILLIPS PETROLEUM COMPANY (US) 1977-01-04 US disclosed
US-3976632-A Reactivation of organochromium olefin polymerization catalyst in presence of oxygen PHILLIPS PETROLEUM COMPANY (US) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361254-A1 HIGH PURITY BIS (ARENE) METAL COMPLEXES FHIT, AP2M1, AP1M1 RXFP1 4885/4885
US-20230271987-A1 ORGANOMETALLIC PRECURSORS AND RELATED METHODS APC, TPR, INTS9 RXFP1 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.